StreetInsider.com News Articles

Kimberly-Clark wins EU approval for Kenvue acquisition

Tue, 13 Oct 2026 10:13:21 -0400

Investing.com -- The European Commission cleared Kimberly-Clark's purchase of Kenvue on Tuesday after the tissue and diaper manufacturer agreed to sell certain feminine hygiene products to address competition concerns.

The maker of Kleenex tissues and Huggies diapers will divest all its tampon and feminine hygiene brands within the European Economic Area as part of the approval conditions, the Commission said in a statement.

The brands included in the divestment are Kotex, which includes the Lidie sub-brand, along with Camelia and Record, according to the EU competition enforcer.

Kenvue manufactures Tylenol pain relief medication.

Kimberly-Clark wins EU approval for Kenvue acquisition

Tue, 13 Oct 2026 10:13:21 -0400

The brands included in the divestment are Kotex, which includes the Lidie sub-brand, along with Camelia and Record, according to the EU competition enforcer.

Kenvue manufactures Tylenol pain relief medication.

Form 8-K Kenvue Inc. For: Oct 09

Tue, 13 Oct 2026 07:27:00 -0400

si-local-file:///var/storage/secattach/20261013/27177028.html

Kimberly-Clark secures consents to amend Kenvue notes in exchange offer

Tue, 13 Oct 2026 07:01:58 -0400

Kimberly-Clark (NASDAQ: KMB) announced it has received the required number of consents to adopt proposed amendments to the indenture governing all outstanding notes issued by Kenvue (NYSE: KVUE), as part of its pending acquisition of the company.

The exchange offers seek to swap Kenvue notes for up to $7 billion in aggregate principal amount of new Kimberly-Clark notes. As of the early participation date of Oct. 9, 2026, holders across all seven series of Kenvue notes had tendered between 73.64% and 98.37% of outstanding principal amounts. Kenvue has executed a supplemental indenture containing the amendments, which will become operative only upon

Kimberly-Clark secures consents to amend Kenvue notes in exchange offer

Tue, 13 Oct 2026 07:01:58 -0400

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

Tue, 13 Oct 2026 07:00:00 -0400

DALLAS, Oct. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today that the requisite number of consents have been received to adopt certain proposed amendments (the "Amendments") with respect to all outstanding notes of Kenvue Inc. (NYSE: KVUE) ("Kenvue"). The results are based on (i) early tenders in the offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes (the

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

Tue, 13 Oct 2026 07:00:00 -0400

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

Tue, 13 Oct 2026 07:00:00 -0400

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

Tue, 13 Oct 2026 07:00:00 -0400

Form 4 Kenvue Inc. For: Oct 02 Filed by: Tillett Caroline